Simulations Plus, Inc.

NASDAQ:SLP

Medical - Healthcare Information Services

Healthcare
$18.50 +0.11%

+$0.02 today

Market cap
$374.16M
Beta
1.32
P/E (TTM)
-5.9
EPS (TTM)
-$3.12
52W Low $11.09High $21.01

Volume 0.00M

Average 0.35M

SLP Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Simulations Plus, Inc.NASDAQ: SLP

Operating Expenses · Q2 FY2026 · quarter ended Feb 2026

Operating expenses grows, but more slowly than its trailing trend

Q2 FY2026 operating expenses of $10.51M rose 0.9% year over year, behind the +193.9% change in trailing-twelve-month operating expenses. Sequentially, it rose 3.3% from the prior quarter. Over 3 fiscal years it compounded at +60.7% a year.

Context

  • Operating expenses amounted to 147.7% of revenue in FY2025, up 94.8 pp from a year earlier.
  • Operating expenses increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +0.9% toward the trailing-twelve-month pace of +193.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$10.51M+3.3% QoQ
Last fiscal yearAug 2025
$116.95M+215.9% YoY
LTMFeb 2026
$117.13M+193.9% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.9%——
1 year+215.9%——
3-year CAGR+60.7%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
116.95M USD
Year-over-year change
+215.9%
4-year CAGR
+47.6%

Operating Expenses vs competitors

How SLP compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +193.9% is the 2nd highest of 11, against a peer median of -14.5%.
  • Operating expenses amounts to 145.4% of revenue for SLP, versus a peer median of 149.4%.
SLP Competitors
Operating Expenses for SLP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NAKANakamoto Inc.LTM Mar 2026$307.53M USD+12143.5%+209.6%7845.8%
AGLAgilon Health, Inc.LTM Mar 2026$233.46M USD-18.8%+2.4%4.0%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$126.37M USD+15.3%-0.1%155.7%
SLPSimulations Plus, Inc.LTM Feb 2026$117.13M USD+193.9%+60.7%145.4%
CLLSCellectis S.A.LTM Mar 2026$101.75M USD+11.1%-1.4%149.4%
KRROKorro Bio, Inc.LTM Mar 2026$85.57M USD-14.7%+14.9%2227.3%
ACIUAC Immune S.A.LTM Mar 2026CHF 68.45M CHF-14.4%-1.1%1849.0%
OPRXOptimizeRx CorporationLTM Mar 2026$59.55M USD-16.5%+3.7%55.5%
NRCNational Research CorporationLTM Mar 2026$57.87M USD+19.1%+4.5%41.7%
DHDefinitive Healthcare Corp.LTM Mar 2026$13.47M USD-98.7%-3.1%5.7%
ANROAlto Neuroscience, Inc.LTM Mar 2026-$55.19M USD-179.1%+31.6%—
Peer median (excluding SLP) —-14.5%+3.0%149.4%

Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Aug 2023
FY2024
Aug 2024
FY2025
Aug 2025
Revenue46.47M53.91M59.58M70.01M79.18M
Cost of Revenue10.6M10.82M11.63M26.86M32.96M
Gross Profit35.87M43.08M47.95M43.15M46.22M
Gross Margin77.2%79.9%80.5%61.6%58.4%
Research & Development4.05M3.21M4.5M5.75M6.88M
Selling, General & Admin20.57M24.97M34.72M31.27M32.85M
Operating Expenses24.61M28.17M39.22M37.02M116.95M
Depreciation & Amortization3.59M3.57M3.84M5.67M8.21M
EBITDA14.7M18.69M13.07M18.08M14.7M
EBITDA Margin31.6%34.7%21.9%25.8%18.6%
Operating Income11.25M14.91M8.73M6.13M(70.73M)
Operating Margin24.2%27.7%14.6%8.8%-89.3%
Interest Income201K717K4.13M4.38M722K
Interest Expense22K0000
Other Income / Expenses(168K)204K2.97M6.28M1.35M
Income Before Tax11.09M15.12M11.7M12.41M(69.38M)
Pre-Tax Margin23.9%28.0%19.6%17.7%-87.6%
Income Tax Expense1.3M2.63M1.73M2.46M(4.66M)
Net Income9.78M12.48M9.96M9.95M(64.72M)
Net Margin21.1%23.2%16.7%14.2%-81.7%
EPS (Basic)0.490.620.500.50(3.22)
EPS (Diluted)0.470.600.490.49(3.22)
Weighted Avg Shares20.05M20.2M20.08M19.99M20.1M
Weighted Avg Shares (Diluted)20.74M20.75M20.47M20.3M20.1M

Simulations Plus, Inc.

NASDAQ:SLP

Intrinsic Alpha fair value

Locked

Current Price

$18.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.